Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. (Q42988930)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

23 February 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Maria Guarino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gian Eugenio Tontini

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

F Morisco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

F Castiglione

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

T Stroffolini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Sansone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R Vitale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

L Biancone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Caruso

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R D'Inca

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R Marmo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Orlando

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Riegler

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

L Donnarumma

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Camera

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

F Zorzi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Renna

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

V Bove

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M Vecchi

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

N Caporaso

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

1 reference

30 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

200-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23383659%20AND%20SRC:MED&resulttype=core&format=json

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

European evidence-based Consensus on the management of ulcerative colitis: Current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Posttransplant lymphoproliferative disease following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Prophylaxis and treatment of hepatitis B in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Hepatitis B and C virus infection in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X

Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01643.X